专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2020180609A1 ENERGY AUGMENTATION STRUCTURES AND THEIR USE IN SOLAR CELLS AND OTHER ENERGY CONVERSION DEVICES 审中-公开
公开(公告)号：WO2020180609A1
公开(公告)日：2020-09-10
申请号：PCT/US2020/020118
申请日：2020-02-27
申请人： IMMUNOLIGHT, LLC.
发明人： BOURKE, Frederic A. Jr. , WALDER, Harold , FATHI, Zakaryae , BEYER, Wayne F. , RUDDER, Ronald A. , BECKER, Daniel I. , SIMMONS, Joseph H.
IPC分类号： H01L31/054 , H01L31/055
摘要： An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, especially in the field of solar cells and other energy conversion devices.

2. 发明申请

WO2020180587A1 ENERGY AUGMENTATION STRUCTURES IN ADHESIVE BONDING COMPOSITIONS 审中-公开
公开(公告)号：WO2020180587A1
公开(公告)日：2020-09-10
申请号：PCT/US2020/020036
申请日：2020-02-27
申请人： IMMUNOLIGHT, LLC.
发明人： BOURKE, Frederic A. Jr. , WALDER, Harold , FATHI, Zakaryae , BEYER, Wayne F. , RUDDER, Ronald A. , SIMMONS, Joseph H.
IPC分类号： C09K11/02 , C09J11/06 , C09J11/04 , C09J9/02
摘要： An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields, including various adhesives applications.

3. 发明申请

WO2020180444A1 ENERGY AUGMENTATION STRUCTURES, ENERGY EMITTERS OR ENERGY COLLECTORS CONTAINING THE SAME, AND THEIR USE IN PLASMONICS ENHANCED METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS 审中-公开
公开(公告)号：WO2020180444A1
公开(公告)日：2020-09-10
申请号：PCT/US2020/016758
申请日：2020-02-05
申请人： IMMUNOLIGHT, LLC.
发明人： BOURKE, Jr., Frederic A. , WALDER, Harold , FATHI, Zakaryae , BEYER, Wayne F. , RUDDER, Ronald A. , SIMMONS, Joseph H.
IPC分类号： A23L3/26 , A23L5/30 , A61K41/00 , A61N5/06 , A61N5/10
摘要： An emission enhancement structure having at least one energy augmentation structure; and an energy converter capable of receiving energy from an energy source, converting the energy and emitting therefrom a light of a different energy than the received energy. The energy converter is disposed in a vicinity of the at least one energy augmentation structure such that the emitted light is emitted with an intensity larger than if the converter were remote from the at least one energy augmentation structure. Also described are various uses for the energy emitters, energy augmentation structures and energy collectors in a wide array of fields.

4. 发明申请

WO2016115225A1 NON-INVASIVE SYSTEMS AND METHODS FOR TREATMENT OF A HOST CARRYING A VIRUS WITH PHOTOACTIVATABLE DRUGS 审中-公开
标题翻译：非侵入性系统和用于治疗携带可摄入药物的病毒的宿主的方法
公开(公告)号：WO2016115225A1
公开(公告)日：2016-07-21
申请号：PCT/US2016/013208
申请日：2016-01-13
申请人： IMMUNOLIGHT, LLC.
发明人： BOURKE, Frederic, Avery , WALDER, Harold
IPC分类号： A61K41/00
CPC分类号： A61K41/0066 , A61K41/0019 , A61K41/0057
摘要： Products, compositions, systems, and methods for treating a subject carrying a virus or bacterium. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to the subject thus producing an effect on or change to a target structure of the subject directly or indirectly. The methods may further be performed by application of an initiation energy to a subject to activate within the subject a photoactivatable drug directly or indirectly, optionally in the presence of one or more plasmonics active agents, thus treating the virus or bacterium. Also provided are kits containing products or compositions formulated or configured and systems for use in practicing these methods.
摘要翻译：用于治疗携带病毒或细菌的受试者的产品，组合物，系统和方法。所述方法可以通过向受试者施加起始能量以非侵入性方式原位进行，从而直接或间接地对受试者的靶结构产生影响或改变。所述方法还可以通过向受试者施用引发能量来进行，以在受试者内直接或间接激活可光活化药物，任选地在一种或多种等离子体激元活性剂的存在下，从而治疗病毒或细菌。还提供了包含配制或配置的产品或组合物和用于实施这些方法的系统的试剂盒。

5. 发明申请

WO2009124189A1 NON-INVASIVE SYSTEMS AND METHODS FOR IN-SITU PHOTOBIOMODULATION 审中-公开
标题翻译：非入侵系统和用于现场光电转换的方法
公开(公告)号：WO2009124189A1
公开(公告)日：2009-10-08
申请号：PCT/US2009/039300
申请日：2009-04-02
申请人： IMMUNOLIGHT, LLC , DUKE UNIVERSITY , BOURKE, Frederic, A. , VO DINH, Tuan , WALDER, Harold
发明人： BOURKE, Frederic, A. , VO DINH, Tuan , WALDER, Harold
IPC分类号： A61K39/395
CPC分类号： A61N5/062 , A61K41/0057 , A61K41/0061 , A61K47/6923 , A61N5/022 , A61N5/0618 , A61N5/0622 , A61N5/10 , A61N2005/0642 , A61N2005/0659 , A61N2005/0661 , A61N2005/0662 , A61N2005/1098
摘要： Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.
摘要翻译：用于修饰介导或与生物学活性相关的靶结构的产物，组合物，系统和方法，包括治疗条件，病症或由靶结构如病毒，细胞，亚细胞结构介导或相关的疾病或胞外结构。所述方法可以通过向受试者施加起始能量以非侵入性方式原位进行，从而直接或经由调节剂产生对靶结构的作用或改变。所述方法还可以通过向受试者原位施加引发能量来直接或经由能量调节剂活化药剂，任选地在存在一种或多种等离子体激元活性剂的情况下进行，由此产生效应或改变目标结构。包含配制或配置的产品或组合的套件以及用于实施这些方法的系统。

6. 发明申请

WO2020077246A1 METHODS, DEVICES, AND COMPOSITIONS FOR MEASURING AND INDUCING CELL-TO-CELL COMMUNICATION, AND THERAPEUTIC USES THEREOF 审中-公开
公开(公告)号：WO2020077246A1
公开(公告)日：2020-04-16
申请号：PCT/US2019/055912
申请日：2019-10-11
申请人： IMMUNOLIGHT, LLC
发明人： BOURKE, JR., Frederic A. , WALDER, Harold , FATHI, Zakaryae , BEYER, Wayne F. , RUDDER, Ronald A.
IPC分类号： A61B18/20 , A61B18/14 , A61K41/00 , A61N5/06
摘要： Methods of treating a subject are provided, involving providing a first region of biological material coupled to the subject; initiating a change in a cellular environment of the cells in the first region; and due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject, along with various biophoton collectors and biophoton bypasses useful for implementing a variety of the method embodiments.

7. 发明申请

WO2018222798A1 X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS 审中-公开
公开(公告)号：WO2018222798A1
公开(公告)日：2018-12-06
申请号：PCT/US2018/035279
申请日：2018-05-31
申请人： IMMUNOLIGHT, LLC , DUKE UNIVERSITY
发明人： BOURKE, Frederic A. , DEWHIRST, Mark , SPECTOR, Neil , YOON, Paul , ADAMSON, Justus , ALCORTA, David , LYERLY, Kim , LIU, Leihua , OSADA, Takuya , OLDHAM, Mark , FATHI, Zakaryae , BEYER, Wayne F. , WALDER, Harold
IPC分类号： A61N5/06 , A61B6/00 , A61K9/00 , A61K49/04 , A61N5/10
摘要： A system (and associated method) for treating a human or animal body. The system has a photoactivatable drug for treating a first diseased site, a first pharmaceutically acceptable carrier including one or more phosphorescent or fluorescent agents which are capable of emitting an activation energy into the body which activates the photoactivatable drug, a first device which infuses the first diseased site with a photoactivatable drug and the first pharmaceutically acceptable carrier, a first energy source which irradiates the diseased site with an initiation energy to thereby initiate emission of the activation energy into the body, and a supplemental treatment device which administers one or both of a therapeutic drug or radiation to the body at a second diseased site or the first diseased site, to provide an immune system stimulation in the body.

8. 发明申请

WO2018170286A1 ADHESIVE BONDING COMPOSITION AND ELECTRONIC COMPONENTS PREPARED FROM THE SAME 审中-公开
公开(公告)号：WO2018170286A1
公开(公告)日：2018-09-20
申请号：PCT/US2018/022669
申请日：2018-03-15
申请人： IMMUNOLIGHT, LLC , FATHI, Zakaryae , CLAYTON, James , WALDER, Harold , BOURKE, Frederic, A.
发明人： FATHI, Zakaryae , CLAYTON, James , WALDER, Harold , BOURKE, Frederic, A.
IPC分类号： C09J183/04 , C09J183/06 , H01L21/762
摘要： A curable resin or adhesive composition includes at least one monomer, a photomitiator capable of initiating polymerization of the monomer when exposed to light, and at least one energy converting material, preferably a phosphor, capable of producing light when exposed to radiation (typically X-rays). The material is particularly suitable for bonding components at ambient temperature in situations where the bond joint is not accessible to an external light source. An associated method includes: placing a polymerizable adhesive composition, including a photoinitiator and energy converting material, such as a down-converting phosphor, in contact with at least two components to be bonded to form an assembly: and, irradiating the assembly with radiation at a first wavelength, capable of conversion (down-conversion by the phosphor) to a second wavelength capable of activating the photoinitiator, to prepare items such as inkjet cartridges, wafer-to-wafer assemblies, semiconductors, integrated circuits, and the like.

9. 发明申请

WO2017136504A1 PHOSPHOR-CONTAINING DRUG ACTIVATOR, SUSPENSION THEREOF, SYSTEM CONTAINING THE SUSPENSION, AND METHODS FOR USE 审中-公开
标题翻译：含磷的药物活化剂，其悬浮液，含有该悬浮液的系统以及使用方法
公开(公告)号：WO2017136504A1
公开(公告)日：2017-08-10
申请号：PCT/US2017/016138
申请日：2017-02-02
申请人： IMMUNOLIGHT, LLC , DUKE UNIVERSITY , NORTH CAROLINA STATE UNIVERSITY
发明人： WALDER, Harold , BOURKE, Frederic A., Jr. , FATHI, Zakaryae , BEYER, Wayne , OLDHAM, Mark , ADAMSON, Justus , NOLAN, Michael
IPC分类号： A61N5/10 , A61K41/00 , A61K49/04
CPC分类号： A61N5/10 , A61K41/0066 , A61N5/062 , A61N2005/0661 , A61N2005/1098
摘要： A phosphor-containing drug activator and suspension thereof are provided. The suspension at least includes two or more phosphors capable of emitting ultraviolet and visible light upon interaction with x-rays. The two or more phosphors include Zn2SiO4:M12+and (3Ca3 (PO4)2Ca(F, CI)2:Sb3*, Mn2+) at a ratio NP-200:GTP-4300 of from 1:10 to 10:1, and each of the two phosphors have an ethylene cellulose coating and/or a diamond-like carbon coating. The suspension further includes a pharmaceutically acceptable carrier. A system for treating a disease in a subject in need thereof includes a) the above-noted suspension, b) a photoactivatable drug containing 8-methoxypsoralen (8-MOP or UVADEX) untethered from the two or more phosphors, c) one or more devices which infuse the photoactivatable drug and the suspension including the pharmaceutically acceptable carrier into a diseased site in the subject, and d) an x-ray source which is controlled to deliver a dose of x-rays to the subject for production of the ultraviolet light.
摘要翻译：提供了含有荧光剂的药物活化剂及其悬浮液。悬浮液至少包括两种或更多种能够在与X射线相互作用时发射紫外线和可见光的荧光体。两种或更多种磷光体包括比例为1:10至10:1的NP-200:GTP-4300的Zn2SiO4：M12 +和（3Ca3（PO4）2Ca（F，Cl）2：Sb3 *，Mn2 +）和两种磷光体中的每一种具有乙烯纤维素涂层和/或类金刚石碳涂层。该悬浮液还包含药学上可接受的载体。用于治疗有此需要的受试者中的疾病的系统包括a）上述悬浮液，b）含有从两种或更多种磷光体未缠结的8-甲氧基补骨脂素（8-MOP或UVADEX）的可光活化药物，c）一种或多种将可光活化药物和包含药学上可接受的载体的悬浮液注入受试者患病部位的装置，以及d）x射线源，其被控制以将一定剂量的x射线输送至受试者用于产生紫外光

10. 发明申请

WO2015195896A1 METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES 审中-公开
标题翻译：用PSORALEN衍生物治疗细胞增殖障碍的方法和系统
公开(公告)号：WO2015195896A1
公开(公告)日：2015-12-23
申请号：PCT/US2015/036401
申请日：2015-06-18
申请人： IMMUNOLIGHT, LLC , DUKE UNIVERSITY
发明人： TOONE, Eric, J. , GOODEN, David , BOURKE, Frederic, A. , WALDER, Harold
IPC分类号： A61K31/37 , A61N5/06 , A61N5/10
CPC分类号： A61N5/062 , A61K31/37 , A61K39/39 , A61N5/0601 , A61N5/0616 , A61N5/10 , A61N2005/0612 , A61N2005/063 , A61N2005/0659 , A61N2005/0661 , A61N2005/0662 , A61N2005/1098 , C07D493/04
摘要： Psoralen compounds of compounds having formulae 1A-10A, 1B-10B, 1C-10C, 1D- 10D, 1E-10E, 1F-10F, 1G-10G, and 1H-5H as shown in Fig. 1, and pharmaceutically acceptable salts thereof; and their use in methods for the treatment of a cell proliferation disorder in a subject, pharmaceutical compositions containing the psoralen derivatives, a kit for performing the method, and a method for causing an auto vaccine effect in a subject using the method.
摘要翻译：具有式1A-10A，1B-10B，1C-10C，1D-10D，1E-10E，1F-10F，1G-10G和1H-5H的化合物的补骨脂素化合物如图1所示。 1及其药学上可接受的盐; 以及它们在治疗受试者细胞增殖障碍的方法中的用途，含有补骨脂素衍生物的药物组合物，用于进行该方法的试剂盒以及使用该方法在受试者中引起自身疫苗效果的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式